Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomized phase I/II pilot study of intermittent withdrawal of antiretroviral therapy as an immunization strategy and double-blinded immunization with ALVAC-HIV vCP1452 in subjects with persistent CD4+ cell counts greater than 400 cells/mm3 and plasma HIV-1 RNA levels less than 50 copies/mL

Next Previous
X
Search
Trial Profile

A randomized phase I/II pilot study of intermittent withdrawal of antiretroviral therapy as an immunization strategy and double-blinded immunization with ALVAC-HIV vCP1452 in subjects with persistent CD4+ cell counts greater than 400 cells/mm3 and plasma HIV-1 RNA levels less than 50 copies/mL

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 02 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs HIV vaccine vCP1452 (Primary) ; Antiretrovirals
  • Indications HIV-1 infections
  • Focus Pharmacodynamics; Therapeutic Use

    • Most Recent Events

    • 11 Mar 2020 Results, assessing the virology determinants of post-treatment control in the participants of A5068 study who underwent A5068 Structured Treatment Interruption, presented at the 27th Conference on Retroviruses and Opportunistic Infections
    • 15 May 2012 Actual patient number changed from 97 to 94 as reported by ClinicalTrials.gov.
    • 05 Oct 2007 Status changed from in progress to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top